form8k13012.htm



 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C.  20549
 
______________
 
 
FORM 8-K
 
______________
 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT
(DATE OF EARLIEST EVENT REPORTED)
 
January 30, 2012
 
______________
 
 
ASTRO-MED, INC
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
______________
 
 
COMMISSION FILE NUMBER       0-13200
 

RHODE ISLAND
05-0318215
(STATE  OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)
(IRS EMPLOYER IDENTIFICATION NUMBER)
 
600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)
 
(401-828-4000)
(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

 




 
 

 


 
Item 8.01.                      Other Events
 

On January 31, 2012, Astro-Med, Inc. (the “Registrant”) announced the divestiture of its label manufacturing operations in Asheboro, North Carolina.  The sale was made to the original owners of Label Line, Ltd.  A copy of the Registrant’s press release regarding the foregoing is attached hereto as Exhibit 99.1.

 
Item 9.01.  Financial Statements and Exhibits
 
 
(c)           Exhibits
 
Exhibit No.          Exhibit
 
 
99.1                  Press Release dated January 31, 2012.
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.
 
  ASTRO-MED, INC.  
       
Date:  January 31, 2012
By:
/s/ Joseph P. O'Connell  
    Joseph P. O'Connell  
    Senior Vice President, Treasurer and Chief Financial Officer